Feedback / Questions
OT-A201 - Onward Therap
https://www.businesswire.com/news/home/20240124510203/en/Biomunex-Pharmaceuticals-Announces-the-Start-of-a-Phase-1-Clinical-Trial-for-Its-First-in-class-Bispecific-Antibody-for-the-Treatment-of-Cancer
Jan 24, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next